Perceptive Advisors LLC, 10% Owner at Prometheus Biosciences, Inc. (RXDX), bought 1,867,770 shares at $19.00 ($16.1M) on 2021-03-16, disclosed to the SEC on 2021-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,017,770 | $0 | 0.0% |
| 2 | $19.00 | 850,000 | $16.1M | 100.0% |
| Total | $8.65 avg | 1,867,770 | $16.1M | 100% |
| Filing → |
| ACRV | SELL | 2025-05-01 | $2.0M | — | Filing → |
| ACRV | SELL | 2025-04-29 | $5.1M | — | Filing → |
| VRCA | BUY | 2023-12-26 | $3.6M | — | Filing → |